Recurrent disease-activity rebound in a patient with multiple sclerosis after natalizumab discontinuations for pregnancy planning

Mult Scler. 2016 Oct;22(11):1506-1508. doi: 10.1177/1352458513492246. Epub 2013 Jun 17.

Authors

Vittorio Martinelli¹, Bruno Colombo², Gloria Dalla Costa², Dacia Dalla Libera², Lucia Moiola², Andrea Falini³, Giancarlo Comi², Massimo Filippi⁴

Affiliations

¹ Department of Neurology, San Raffaele Hospital, Milan, Italy vittorio.martinelli@hsr.it.
² Department of Neurology, San Raffaele Hospital, Milan, Italy.
³ Department of Neuroradiology, San Raffaele Hospital, Milan, Italy.
⁴ Neuroimaging Research Unit, San Raffaele Scientific Institute, Milan, Italy.

PMID: 23773984
DOI: 10.1177/1352458513492246

No abstract available

Publication types

Letter

MeSH terms

Adolescent
Brain / pathology*
Chronic Disease
Female
Humans
Multiple Sclerosis / drug therapy*
Natalizumab / therapeutic use*
Pregnancy
Recurrence
Treatment Outcome

Substances

Natalizumab